Expert Interview
Digging into the breakthrough results from a survodutide Phase 2 trial sub-analysis in MASH and Liver Fibrosis
Ticker(s): BOEHRINGER INGELHEIM, ZEALInstitution: NYU Langone
- Adjunct Assistant Professor of Gastroenterology/Hepatology, Department of Medicine at NYU Grossman Long Island School of Medicine
- Manages 75 patients with MASH annually
- Clinical and research interest in Inflammatory Bowel Disease and Fatty Liver Disease
Roughly how many patients with NASH do you currently manage?
Added By: ben_adminOn a scale from 1-10 (10 being extremely excited) where would you rate your level of excitement for survodutide?
Added By: ben_adminWhere would you expect Survodutide to fit into your treatment algorithm of MASH?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
